SWM
RDY icon

SHP Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

SHP Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.49K Sell
448
-56
-11% -$755 ﹤0.01% 1099
2026
Q1 		$6.98K Buy
+504
New +$7.02K ﹤0.01% 989

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

SHP Wealth Management's RDY Position: Q2 2026 in Review

SHP Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 11% in Q2 2026, selling an estimated $755 and leaving 448 shares worth $6.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

SHP Wealth Management first reported a position in RDY in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.98K in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • SHP Wealth Management held 448 shares of Dr. Reddy's Laboratories worth $6.49K as of Q2 2026.
  • SHP Wealth Management sold 56 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $755.
  • Dr. Reddy's Laboratories made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1099 holding.
  • SHP Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2026 and has held it in 2 quarters since.
  • SHP Wealth Management's Dr. Reddy's Laboratories position peaked at $6.98K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.